Selected Publications:
Bagley SJ, Talento S, Mitra N, Meropol NJ, Cohen RB, Langer CJ, Vachani A: Comparative Effectiveness of Carboplatin-Pemetrexed With vs Without Bevacizumab in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer Journal of the National Comprehensive Cancer Network 15 (5): 469-477,2019.
Kossenkov AV, Qureshi R, Dawany NB, Wickramasinghe J, Liu Q, Majumdar RS, Chang C, Widura S, Kumar T, Horng WH, Konnisto E, Criner G, Tsay JJ, Pass H, Yendamuri S, Vachani A, Bauer T, Nam B, Rom WN, Showe MK, Showe LC: A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT Cancer Research 79 (1): 263-73,2019.
Thompson JC, Fan R, Black T, Yu GH, Savitch SL, Chien A, Yee SS, Sen M, Hwang WT, Katz SI, Feldman M, Vachani A, Carpenter EL.: Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients. Lung Cancer 127 : 25-33,2019.
Weng L, Guo L, Vachani A, Mesaros C, Blair IA.: Quantification of Serum High Mobility Group Box 1 by Liquid Chromatography/High-Resolution Mass Spectrometry: Implications for Its Role in Immunity, Inflammation, and Cancer Anal Chem 90 (12): 7552-7560,2018.
Silvestri GA, Tanner NT, Kearney P, Vachani A, Massion PP, Porter A, Springmeyer SC, Fang KC, Midthun D, Mazzone PJ; PANOPTIC Trial Team: Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial Chest : 2018.
Morris S, Vachani A, Pass HI, Rom WN, Ryden K, Weiss GJ, Hogarth DK, Runger G, Richards D, Shelton T, Mallery DW: Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer Int J Cancer : 2018.
Huang J., Liu Y., Vitale S., Penning T.M., Whitehead A.S., Blair I.A., Vachani A., Clapper M., Muscat J.E., Lazarus P., Scheet P., Moore J.H., Chen Y.: On meta- and mega-analyses for gene–environment interactions Genetic Epidemiology : 2017.
Aggarwal C, Wang X, Ranganathan A, Torigian D, Troxel A, Evans T, Cohen RB, Vaidya B, Rao C, Connelly M, Vachani A, Langer C, Albelda S: Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy Lung Cancer 112 : 118-125,2017.
Tanner NT, Porter A, Gould MK, Li XJ, Vachani A, Silvestri GA: Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest 152 (2): 263-270,2017.
Xu R, Mesaros C, Weng L, Snyder NW, Vachani A, Blair IA, Hwang WT: Comparison of statistical methods for detection of serum lipid biomarkers for mesothelioma and asbestos exposure. Biomarkers in Medicine 11 (7): 547-556,2017.